Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Shire Presented Results Of A New Database Analysis On Lialda(R) (Mesalamine) And Other 5-ASAs For Ulcerative Colitis At Digestive Disease Week
Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, presented the results of a 5-aminosalicylic acid (5-ASA) persistency analysis entitled, "Twelve-month Persistence with 5-aminosalicylic Acid Therapy: Results from a Large Pharmacy Database," at Digestive Disease Week, on May 31, 2009. Results showed that after 12 months of therapy for continuing patients, 20 percent of Lialda patients were continually persistent, 9 percent of Asacol(R) (mesalamine) patients, 7 percent (250mg) and 10 percent (500mg) of Pentasa(R) (mesalamine) patients, 10 percent of balsalazide [combined results from generic balsalazide disodium and Colazal(R) (balsalazide disodium)] patients, and 10 percent (500mg) of Dipentum(R) (olsalazine sodium) patients were persistent. Continually persistent patients were defined as those who refilled their prescription within a period of up to twice the duration of the prescription that preceded the refill. Lialda is an FDA-approved, once-daily oral medication for the induction of remission in patients with active, mild to moderate ulcerative colitis (UC). Safety and effectiveness of Lialda beyond eight weeks have not been established.
generic viagra online
Verdict Reached In Landmark Mental Health Employment Case
Cheltenham Borough Council has today lost its case to sue former employee Christine Laird for ÷£1million for not disclosing her past experience of depression. Leading mental health charity Mind says the landmark ruling serves as an important reminder to employers about the importance of providing adequate support to people with mental health problems in the workplace.
News of the day
Achaogen Data Show Rapid Rise In Rates Of Resistance To Current Antibiotics
Achaogen, a clinical stage biopharmaceutical company addressing the issue of multi-drug resistant bacterial infections through the discovery and development of innovative broad-spectrum antibiotics, announced today the presentation of research on aminoglycoside (AG) resistance trends and comparative AG toxicities at the 19th Annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), being held May 16-19, 2009 in Helsinki, Finland.
Health Insurance

Mid-Missouri Group Sees Increase In People Seeking HIV/AIDS Services, Patients Testing Positive For HIV

Mid-Missouri Group Sees Increase In People Seeking HIV/AIDS Services, Patients Testing Positive For HIV Mid-Missouri has experienced an 18 percent increase in people seeking treatment for HIV/AIDS, according to RAIN, the organization that handles case management for patients in the area, AP/Springfield News-Leader reports (7/5). Cale Mitchell, executive director of RAIN, said in the 12 month period ending in May, the group added 58 clients who either tested positive for HIV or began seeking services. "Some of that increase can be explained by more widespread testing by local agencies and clinics, but other factors include a casual attitude toward the disease among young people and a perception that HIV is a treatable condition because of medical advances," writes the Columbia Daily Tribune (Greaney, 7/5). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009